Abstract |
Cryptosporidium parvum (Cp) is a potential biowarfare agent and major cause of diarrhea and malnutrition. This protozoan parasite relies on inosine 5'-monophosphate dehydrogenase (IMPDH) for the production of guanine nucleotides. A CpIMPDH-selective N-aryl-3,4-dihydro-3-methyl-4-oxo-1-phthalazineacetamide inhibitor was previously identified in a high throughput screening campaign. Herein we report a structure-activity relationship study for the phthalazinone-based series that resulted in the discovery of benzofuranamide analogs that exhibit low nanomolar inhibition of CpIMPDH. In addition, the antiparasitic activity of select analogs in a Toxoplasma gondii model of C. parvum infection is also presented.
|
Authors | Corey R Johnson, Suresh Kumar Gorla, Mandapati Kavitha, Minjia Zhang, Xiaoping Liu, Boris Striepen, Jan R Mead, Gregory D Cuny, Lizbeth Hedstrom |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 23
Issue 4
Pg. 1004-7
(Feb 15 2013)
ISSN: 1464-3405 [Electronic] England |
PMID | 23324406
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- Antiparasitic Agents
- Enzyme Inhibitors
- Phthalazines
- IMP Dehydrogenase
|
Topics |
- Antiparasitic Agents
(pharmacology)
- Cryptosporidiosis
(drug therapy)
- Cryptosporidium parvum
(drug effects, enzymology)
- Enzyme Inhibitors
(chemistry, pharmacology)
- Humans
- IMP Dehydrogenase
(antagonists & inhibitors, metabolism)
- Phthalazines
(chemistry, pharmacology)
- Structure-Activity Relationship
|